T0070907

CAS No. 313516-66-4

T0070907( T0070907, T-0070907, T 0070907 )

Catalog No. M14008 CAS No. 313516-66-4

T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
5MG 43 In Stock
10MG 50 In Stock
25MG 88 In Stock
50MG 140 In Stock
100MG 193 In Stock
200MG 250 In Stock
500MG 421 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    T0070907
  • Note
    Research use only, not for human use.
  • Brief Description
    T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM.
  • Description
    T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM, with a >800-fold selectivity over PPARα and PPARδ.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    T0070907, T-0070907, T 0070907
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPARα| PPARγ| PPARδ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    313516-66-4
  • Formula Weight
    277.66
  • Molecular Formula
    C12H8ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 26 mg/mL (93.63 mM)
  • SMILES
    O=C(NC1=CC=NC=C1)C2=CC([N+]([O-])=O)=CC=C2Cl
  • Chemical Name
    2-chloro-5-nitro-N-(pyridin-4-yl)benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lee G et al. J Biol Chem, 2002, 277(22), 19649-19657.
molnova catalog
related products
  • Suksdorfin

    Suksdorfin has hypoglycemic effects, promotes adipocyte differentiation and enhances lipocalin production, activates peroxisome proliferator-activated receptor gamma (PPARγ), promotes insulin-dependent glucose uptake by adipocytes, and can be used to study obesity.

  • Balaglitazone

    Balaglitazone is a selective peroxisome proliferator-activated receptor (PPARγ) partial agonist with an EC50 value of 1.351 μM for human PPARγ.

  • Arhalofenate

    Arhalofenate is a selective partial agonist of peroxisome proliferator-activated receptor PPARγ. It is used for the treatment of type 2 diabetes.